We are live on ! Find out more
JNJ icon

Johnson & Johnson

2,121 hedge funds and large institutions have $206B invested in Johnson & Johnson in 2014 Q4 according to their latest regulatory filings, with 206 funds opening new positions, 782 increasing their positions, 910 reducing their positions, and 51 closing their positions.

New
Increased
Maintained
Reduced
Closed

304% more first-time investments, than exits

New positions opened: 206 | Existing positions closed: 51

7% more funds holding

Funds holding: 1,9882,121 (+133)

4% more capital invested

Capital invested by funds: $199B → $206B (+$7.19B)

0.1% less ownership

Funds ownership: 66.11%66.01% (-0.1%)

8% less funds holding in top 10

Funds holding in top 10: 720659 (-61)

14% less repeat investments, than reductions

Existing positions increased: 782 | Existing positions reduced: 910

34% less call options, than puts

Call options by funds: $1.66B | Put options by funds: $2.52B

Holders
2,121
Holders Change
+133
Holders Change %
+6.69%
% of All Funds
56.54%
Holding in Top 10
659
Holding in Top 10 Change
-61
Holding in Top 10 Change %
-8.47%
% of All Funds
17.57%
New
206
Increased
782
Reduced
910
Closed
51
Calls
$1.66B
Puts
$2.52B
Net Calls
-$858M
Net Calls Change
-$373M
Name Holding Trade Value Shares
Change
Change in
Stake
First Manhattan
101
First Manhattan
New York
$279M -$4.76M -45,185 -2%
Adage Capital Partners
102
Adage Capital Partners
Massachusetts
$276M -$34.2M -324,600 -11%
D.E. Shaw & Co
103
D.E. Shaw & Co
New York
$266M +$67.7M +642,078 +34%
Citigroup
104
Citigroup
New York
$264M +$23.7M +225,202 +10%
Bessemer Group
105
Bessemer Group
New Jersey
$263M +$53.4M +507,133 +25%
Ninety One (UK)
106
Ninety One (UK)
United Kingdom
$262M -$2.43M -23,097 -0.9%
JWBC
107
John W. Bristol & Co
New York
$262M -$4.36M -41,401 -2%
Chevy Chase Trust
108
Chevy Chase Trust
Maryland
$260M -$2.75M -26,051 -1%
Lazard Asset Management
109
Lazard Asset Management
New York
$260M -$9.75M -92,528 -4%
GT
110
Glenmede Trust
Pennsylvania
$255M +$7.39M +70,138 +3%
Comerica Bank
111
Comerica Bank
Texas
$250M +$102M +969,157 +68%
PI
112
PGGM Investments
Netherlands
$247M -$20.7M -196,781 -8%
PAM
113
Panagora Asset Management
Massachusetts
$247M -$15.5M -147,553 -6%
PAMU
114
Pictet Asset Management (UK)
United Kingdom
$247M +$17.5M +166,372 +8%
MNA
115
Manning & Napier Advisors
New York
$247M -$5.17M -49,023 -2%
GE
116
General Electric
Ohio
$246M -$115M -1,089,396 -32%
JFL
117
Jarislowsky, Fraser Ltd
Quebec, Canada
$245M -$5.26M -49,936 -2%
TG
118
TCW Group
California
$245M -$43.7M -415,039 -15%
Renaissance Technologies
119
Renaissance Technologies
New York
$244M -$32.3M -306,300 -12%
Federated Hermes
120
Federated Hermes
Pennsylvania
$244M -$130M -1,235,118 -35%
BTS
121
BB&T Securities
Virginia
$243M -$68.8K -653 -0.3%
Fiera Capital (Canada)
122
Fiera Capital (Canada)
Quebec, Canada
$235M +$22.8M +216,248 +11%
Axa
123
Axa
France
$235M +$14M +133,046 +6%
Mackenzie Financial
124
Mackenzie Financial
Ontario, Canada
$235M +$25.6M +242,733 +12%
AT
125
AMF Tjänstepension
Sweden
$234M +$235M +2,233,031 New

JNJ Hedge Fund Activity: Q4 2014 in Review

2,121 of the 3,751 institutional investors tracked by Wall St. Rank reported a position in Johnson & Johnson (JNJ) for Q4 2014, worth a combined $206B — up 3.6% from $199B a quarter earlier.

Buyers outnumbered sellers: 206 funds opened new JNJ positions and 51 closed out — a net gain of 155 holders — while 782 added to existing stakes and 910 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $920M. The largest seller was T. Rowe Price Associates, cutting an estimated $652M.

  • 2,121 institutional investors held Johnson & Johnson (JNJ) as of Q4 2014, up from 1,988 in Q3 2014.
  • Funds reported $206B of Johnson & Johnson stock for Q4 2014, up 3.6% quarter-over-quarter.
  • 206 funds opened new Johnson & Johnson positions in Q4 2014 and 51 closed out, a net change of +155 holders.
  • The largest Johnson & Johnson buyer in Q4 2014 was Fidelity Investments, an estimated $920M added.
  • The largest Johnson & Johnson seller in Q4 2014 was T. Rowe Price Associates, an estimated $652M sold.

Based on aggregated 13F filings for Q4 2014.